Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of United ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

but ran into obstacles as United Therapeutics blocked access to the drug's administration devices, which slowed the competitor's spread. Key industry trends include the growth of the PH-ILD market ...

United Therapeutics, which belongs to the Zacks Medical - Drugs industry, posted revenues of $735.9 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.46%.

Biotechnology company United Therapeutics (NASDAQ:UTHR) in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per share was 1.2% below analysts’ consensus ...

United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The business’s fifty day moving average price is $349.12 and its 200 day moving average price is $358.27.

a half-decade historical view may miss recent innovations or disruptive industry trends. United Therapeutics’s annualized revenue growth of 21.9% over the last two years is above its five-year ...

Rising Healthcare Costs and the Impact of Tariffs on the US Industry In the US ... RESEARCH TRIANGLE PARK, N.C., March 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ ... In 2023, the healthcare industry made up around 17.6% of the US economy, up 17.4% from 2022. The ...

We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. United Therapeutics ...